Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: bleomycins / strawberry / pineapple attending: chief complaint: s/p fall major surgical or invasive procedure: none history of present illness: 85m with pmh of both hodgkins and non-hodgkins lymphoma currently on chemo who presented to an osh after a fall in his driveway, pt was noted to be febrile and tachycardic in ed so transferred to icu for further evaluation and work-up. patient reports that he accidentally tripped and fell while out on a walk. he reports that he bumped his head in the fall. he was found down by his neighbor and ems was called. the patient states that he awoke in the ambulance. he was initially taken to where an ekg was performed that was concerning for st-segment elevations. patient received one dose of atorvastatin and cardiac enzymes were negative x1. his cbc was significant for a white count of 13.8 with an 18% bandemia. the patient was then transferred to on a nitro gtt for admission to cardiology for stemi. upon arrival in the ed, vitals were 99.6 hr 80-140s 130/77 22 97% on 3l. the ekgs were reviewed by cardiology and were not read as st-segment elevations. nitro gtt was stopped. cardiac enzymes were cycled and negative x1. ekg was notable for sinus tachycardia to the 140s. patient was reportedly asymptomatic. a head ct was performed at the osh that was reported as negative. a ct scan of c/a/p was done in the ed that was negative for pulmonary emboli and intra-abdominal pathology but he was noted to have a small-moderate pericardial effusion. in addition to the tachycardia, the patient was later febrile to 102. the patient was again noted to have an elevated white blood cell count with a bandemia of 8%. patient was given 4l of ns, blood and urine cultures were sent. ua negative. patient was started on vanc and levaquin and given one dose of tylenol. the patient's primary oncologist is . he is scheduled to received cycle 19 of gemzar/navelbine today. patient has also been on neulasta, last received on . on transfer to the oncology floor pt was still noted to be intermittently in atrial tachycardia, asymptomatic with it. cardiology consulted and pt was changed from a daily atenolol dose to metoprolol dosing. past medical history: hodgkin lymphoma: relapsed disease: in , he was markedly symptomatic with fatigue, feeling lousy, and weight loss.bone marrow examination in showed extensive involvement by hodgkin lymphoma. torso ct scan (full report on omr) was mostly unremarkable; spleen was normal. original disease: in , mr. became increasingly fatigued. he had poor appetite and worsening anemia. bone marrow exam demonstrated cd30+ hodgkin's disease. he then received dose-modified abvd chemotherapy. adriamycin and vinblastine have been dose reduced by 25%. he had an immediate reaction to the bleomycin and did not received further bleomycin. in , repeat bone marrow showed no evidence of lymphoma or hodgkin's disease either by flow cytometry or by histology. non-hodgkin's lymphoma: mr. had been previous treated first for non-hodgkin's lymphoma and later for hodgkin's disease. herb presented initially with a low grade lymphoma/massive splenomegaly. he received 6 cycles of cvp-rituxan chemotherapy, and had a dramatic response to chemotherapy. his symptoms, fatigue and loss of appetite, resolved. in herb began a course of rituxan x 4 as part of a maintenance program. other issues: he had a right leg common femoral artery to posterior tibial bypass by the surgery service, and then had a successful right lower vein graft angioplasty (). he had an episode of syncope (). no further syncopal issues. cardiac echo shows left ventricular wall thickness, cavity size, and systolic function are normal (lvef>55%). no change from . social history: married, former professor , graduate of business school. former smoker, quit . social etoh. 4 kids, 5 grandchildren family history: non-contributory physical exam: general appearance: well nourished, no acute distress eyes / conjunctiva: perrl, no(t) pupils dilated, no(t) sclera edema head, ears, nose, throat: normocephalic, poor dentition, no(t) endotracheal tube, no(t) ng tube, no(t) og tube, abrasions on lower lip and chin lymphatic: cervical wnl, supraclavicular wnl, no(t) cervical adenopathy cardiovascular: (s1: normal), (s2: distant), no(t) s3, no(t) s4, (murmur: no(t) systolic, no(t) diastolic), distant heart sounds peripheral : (right radial pulse: not assessed), (left radial pulse: not assessed), (right dp pulse: diminished), (left dp pulse: diminished) respiratory / chest: (expansion: symmetric), (breath sounds: clear : , no(t) crackles : , no(t) bronchial: , no(t) wheezes : , no(t) diminished: , no(t) absent : , no(t) rhonchorous: ) abdominal: soft, non-tender, bowel sounds present, no(t) distended, no(t) obese extremities: right: absent, left: absent musculoskeletal: no(t) muscle wasting skin: warm, no(t) rash: , no(t) jaundice neurologic: attentive, follows simple commands, responds to: verbal stimuli, no(t) oriented (to): , movement: purposeful, tone: not assessed pertinent results: 12:00am blood wbc-11.9* rbc-3.18* hgb-10.1* hct-30.5* mcv-96 mch-31.6 mchc-32.9 rdw-20.0* plt ct-322 12:00am blood wbc-10.1 rbc-2.77* hgb-8.7* hct-26.4* mcv-95 mch-31.4 mchc-33.0 rdw-20.0* plt ct-315 12:00am blood wbc-11.1* rbc-2.61* hgb-8.6* hct-25.3* mcv-97 mch-32.9* mchc-34.1 rdw-20.3* plt ct-313 12:00am blood wbc-10.7 rbc-2.78* hgb-8.8* hct-26.3* mcv-95 mch-31.4 mchc-33.3 rdw-20.1* plt ct-330 12:00am blood wbc-11.9* rbc-3.18* hgb-10.1* hct-30.5* mcv-96 mch-31.6 mchc-32.9 rdw-20.0* plt ct-322 12:00am blood wbc-10.1 rbc-2.77* hgb-8.7* hct-26.4* mcv-95 mch-31.4 mchc-33.0 rdw-20.0* plt ct-315 12:00am blood wbc-11.1* rbc-2.61* hgb-8.6* hct-25.3* mcv-97 mch-32.9* mchc-34.1 rdw-20.3* plt ct-313 10:57am blood wbc-12.8* rbc-2.72* hgb-8.5* hct-25.9* mcv-95 mch-31.3 mchc-32.9 rdw-20.0* plt ct-265 11:00pm blood wbc-18.5*# rbc-3.36* hgb-10.9* hct-33.4* mcv-100* mch-32.4* mchc-32.6 rdw-19.3* plt ct-271 12:00am blood pt-23.1* ptt-30.9 inr(pt)-2.2* 12:00am blood pt-21.6* ptt-104.5* inr(pt)-2.1* 12:00am blood pt-21.2* ptt->150* inr(pt)-2.0* 12:00am blood glucose-292* urean-25* creat-1.3* na-132* k-4.7 cl-101 hco3-19* angap-17 12:00am blood glucose-156* urean-17 creat-1.1 na-138 k-4.3 cl-107 hco3-24 angap-11 12:00am blood glucose-273* urean-20 creat-1.3* na-132* k-4.2 cl-107 hco3-22 angap-7* 12:00am blood glucose-215* urean-20 creat-1.2 na-136 k-4.2 cl-104 hco3-22 angap-14 12:00am blood calcium-8.3* phos-3.8 mg-2.0 12:00am blood calcium-8.1* phos-2.7 mg-1.9 04:06am blood caltibc-143* vitb12-greater th folate-greater th ferritn-greater th trf-110* 10:57am blood tsh-5.1* = = = = = = = = = ================================================================ echo: the left atrium is normal in size. left ventricular wall thicknesses are normal. the left ventricular cavity size is normal. overall left ventricular systolic function is low normal (lvef 50%). right ventricular chamber size is normal. with focal hypokinesis of the apical free wall. the ascending aorta is mildly dilated. the aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. no aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. there is no mitral valve prolapse. trivial mitral regurgitation is seen. the pulmonary artery systolic pressure could not be determined. there is a small pericardial effusion. the effusion appears circumferential. there are no echocardiographic signs of tamponade. no right atrial or right ventricular diastolic collapse is seen. compared with the findings of the prior report (images unavailable for review) of , the right ventricle is no longer dilated and globally hypocontractile. indication: fever, tachycardia and fall. technique: mdct-acquired axial images of the abdomen and pelvis were obtained without oral or iv contrast as the patient could not tolerate fluids and had a recent iv contrast. comparison: . ct abdomen: there is a moderate-sized pericardial effusion. there is atherosclerotic calcification in the thoracic aorta. there is mild dependent atelectasis at the lung bases. evaluation of the solid organs is somewhat limited by the lack of iv contrast: the liver, pancreas, and spleen are normal. the patient has had prior cholecystectomy. the right adrenal nodule measures 23 x 18 mm (2:20), similar to prior study. the left adrenal is normal. there is calcification of the aorta, the splenic artery, the origin of the sma and the renal arteries as well as the common, external and internal iliac arteries. there is no free fluid, free air, or adenopathy. the intra- abdominal small and large bowel is normal. ct pelvis: the rectum, sigmoid, and bladder are normal. there is a foley in the bladder. there is no free fluid, inguinal or pelvic adenopathy. bone windows: there is degenerative change in the lumbar spine. the minimally displaced right 12th rib fracture is again noted. impression: 1. no acute intra-abdominal process. 2. minimally displaced right 10th rib fracture, which is chronic. 3. diffuse calcifications. brief hospital course: 85 y.o. male w/ hodgkin's and non-hodgkin's lymphoma undergoing chemotherapy with gemzar/ transferred to from osh for questionable st elevation s/p fall, transferred to oncology following negative fever, cardiac work up now with unsteady gait likely hospitalization, asymptomatic atrial tachycardia. # fever, hypotension, leukocytosis with bandemia: upon admission to the icu pt was noted to have a low bp, tachycardia, fevers and leukocytosis meeting sirs. pt was hydrated with iv fluids, work up included a ct chest/abdomen scan which showed a small pericardial effusion, no evidence of pulmonary embolism, no intraabdominal process. following negative cultures, and fevers in spite of antibiotic therapy, pt's fevers were attributed to his lymphoma and his leukocytosis with bandemia was atrributed to the pt's recent neulasta treatment prior to admission. prior to discharge pt was afebrile with leukocytosis only returning with onset of neupogen. # atrial tachycardia: during hospitalization pt has intermittently going into atrial tachycardia usually with a heart rate in the 120s, he has been asymptomatic during these episodes and this may have been the inciting event for the pt's fall on admission. in the icu pt was started on an esmolol drip which showed no effect, pt spontaneously went back into sinus after it was discotninued. pt then went into nsvt was trialed on amiodarone, and then per cardiology recommendations, was switched back to beta-blockade therapy. since his transfer to the oncology floor cardiology has been following the patient, it is unclear as to the cause of the pt's atrial tachycardia or how long he has had these episodes for. recommend continuing beta-blocker therapy, specifically metoprolol tartrate three times a day (62.5mg at 0700, 62.5mg at 1300, 50mg at 2100). # hodgkin's and non-hodgkin's lymphoma: pt's primarty oncologist is dr. , prior to discharge pt was started on his 19th cycle of gemzar/navelbine. he will need to complete a 7 day course of neupogen 300mcg s.c. daily, his last dose of this medication will be . pt eas also received 1 unit of blood transfusion day prior to discharge. # hyperglycemia: pt is noted to be hyperglycemic on day of discharge, most likely due to the iv dexamethasone pt was on yesterday for his chemotherapy. will continue pt on iss. # history of pe: pt is currently on coumadin for his history of pulmonary embolism. please check inr every two days and adjust warfarin accordingly for a goal inr of . # hyperlipidemia: pt was continued on his home regimen of simvastatin. # renal insufficiency; pt has a history of renal insufficiency with a baseline creatinine 1.2-1.3. # bph: pt has been continued on his home regimen of doxazosin. # fall: pt was admitted from an outside hospital following a fall, it is unclear as to why he feel but it may be related to his atrial tachycardia. since admission to the hospital pt has decompensated and has not been able to ambulate as readily as he did before. prior to hospitalization pt was able to ambulate long distances daily and now requires help when ambulating. physical therapy recommended rehab placement. # code status: full code medications on admission: allopurinol - 100mg tablet - one p.o. every day aspirin - 81 mg tablet - 1 tablet(s) by mouth qday doxazosin - 2 mg tablet - 1 tablet(s) by mouth at bedtime gabapentin - 400 mg capsule - 1 capsule(s) by mouth three times a day megestrol - 625 mg/5 ml suspension - 5 ml (one teaspoon) suspension(s) by mouth once daily metoprolol tartrate - (prescribed by other provider) - 50 mg tablet - 1 tablet(s) by mouth once a day simvastatin - 10 mg tablet - 1 tablet(s) by mouth once a day in the evening warfarin - (prescribed by other provider) - 2.5 mg tablet - 1 tablet(s) by mouth q mon, wed, & warfarin - 5 mg tablet - one tablet(s) by mouth q , , , & sat discharge medications: 1. allopurinol 100 mg tablet sig: one (1) tablet po daily (daily). 2. aspirin 81 mg tablet, chewable sig: one (1) tablet, chewable po daily (daily). 3. simvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 4. megestrol 400 mg/10 ml suspension sig: two (2) po daily (daily). 5. doxazosin 1 mg tablet sig: two (2) tablet po hs (at bedtime). 6. gabapentin 300 mg capsule sig: one (1) capsule po q 12h (every 12 hours). 7. warfarin 2.5 mg tablet sig: one (1) tablet po qmowefr (monday -wednesday-friday). 8. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) as needed for constipation. 9. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 10. warfarin 5 mg tablet sig: one (1) tablet po qtuthsa + qsun (). 11. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) as needed for constipation. 12. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) as needed for constipation. 13. filgrastim 300 mcg/ml solution sig: one (1) injection q24h (every 24 hours) for 6 days: please start . 14. metoprolol tartrate 50 mg tablet sig: one (1) tablet po daily (daily): please give at 2100. 15. metoprolol tartrate 50 mg tablet sig: one (1) tablet po once a day: please give at 1300. please give with 12.5mg metoprolol for a total dose of 62.5mg. 16. metoprolol tartrate 50 mg tablet sig: one (1) tablet po qam (once a day (in the morning)): please give at 0700. please give with 12.5mg metoprolol for a total dose of 62.5mg. 17. insulin lispro 100 unit/ml solution sig: one (1) unit subcutaneous four times a day: take per insulin sliding scale. 18. metoprolol tartrate 25 mg tablet sig: 0.5 tablet po once a day: please give at 0700. please give with 50mg metoprolol for a total dose of 62.5mg. 19. metoprolol tartrate 25 mg tablet sig: 0.5 tablet po once a day: please give at 1300. please give with 50mg metoprolol for a total dose of 62.5mg. discharge disposition: extended care facility: - discharge diagnosis: primary diagnoses: atrial tachycardia, hodgkin's lymphoma secondary diagnoses: - renal insufficiency - hypertension - peripheral disease - h/o pulmonary embolism and right dvt on warfarin discharge condition: stable, afebrile. discharge instructions: you were transferred to this hospital after falling because there was a concern about your heart readings. whilst in the icu our tests showed you didn't have a heart attack but your heart rate was beating fast. we started you on a new heart medication that has kept your heart at a normal rate. during your hospital stay you had difficulty walking with full strength which is why we recommended you got to a rehabilitation facility. you also experienced some fevers which we believe is due to your cancer. you also received your 19th cycle of chemotherapy with a unit of blood before you were discharged to rehab. you have been started on several new medications: 1. please take metoprolol tartrate 62.5mg every day at 0700. 2. please take metoprolol tartrate 62.5mg every day at 1300. 3. please take metorpolol tartrate 50mg every day at 2100. 4. please take 7 days of filgrastime 300mcg every day, your last dose of this medication will be on . followup instructions: provider: , md phone: date/time: 2:00 provider: , m.d. phone: date/time: 9:30 provider: lab phone: date/time: 2:00 provider: , md phone: date/time: 2:45 md, procedure: transfusion of packed cells injection or infusion of cancer chemotherapeutic substance diagnoses: acidosis other specified disorders of pancreatic internal secretion adrenal cortical steroids causing adverse effects in therapeutic use atherosclerosis of aorta hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified fall peripheral vascular disease, unspecified personal history of tobacco use hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic kidney disease, unspecified mononeuritis of lower limb, unspecified paroxysmal ventricular tachycardia unspecified disease of pericardium other specified cardiac dysrhythmias hodgkin's disease, unspecified type, unspecified site, extranodal and solid organ sites long-term (current) use of anticoagulants personal history of venous thrombosis and embolism diarrhea systemic inflammatory response syndrome due to noninfectious process without acute organ dysfunction leukocytosis, unspecified history of fall difficulty in walking other agents affecting blood constituents causing adverse effects in therapeutic use 

Answer: The patient is high likely exposed to